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ehe Cardiovascular Disease in Asian and Pacific Islander
opulations NHLBI Working Group paper in this issue of
he Journal (1) outlines an initiative to study Asian Amer-
can groups with regard to their risk of diabetes and
ardiovascular disease. The impetus stems from the increas-
ng population of Asian immigrants in the U.S. Comparing
he 1990 and 2000 U.S. Census data, there was a 48.3%
ncrease in the number of citizens of Asian origin and a
.3% increase in those of Native Hawaiian or other Pacific
sland origin (2). In addition, Asian immigrants make up a
ignificant proportion of foreign-born people; 23.4% are
sian, 0.3% are Native Hawaiian or Pacific Islander (3).
iven the changing U.S. population and to better serve
atients, it is important to assess the particular risk factors of
hese groups.
hy Are These Studies Important?
pecific population studies have become more important in
he era of personalized medicine. The current tools that we
ave to assess risk may not be applicable in Asian Ameri-
ans. Studies have shown that Framingham study risk
actors were not enough to account for the prevalence of
ardiovascular disease seen among Asian Americans. More-
ver, there is a disparate risk profile between Asians and
ther groups and within the different Asian groups them-
elves (4).
A large epidemiology study can elucidate the underlying
enetics, pathophysiological differences, and biological
echanism of cardiovascular disease risk factors in ethnic
opulations. Studies of this nature will help us to better
efine groups at risk and design optimal prevention and
reatment plans for these groups, which will have major
mplications for future public health cost. There have been
nstances of more personalized treatments in other Ameri-
an ethnic groups. For example, a subgroup analysis of
LLHAT (Antihypertensive and Lipid-Lowering Treat-
ent to Prevent Heart Attack Trial) of African-American
atients found angiotensin-converting enzyme inhibitors to
e less effective than calcium-channel blockers or thiazide
rom the Cleveland Clinic, Department of Cardiovascular Medicine, Cleveland,d
hio.
Manuscript received August 24, 2009; accepted August 26, 2009.iuretics in lowering blood pressure (5). This 5 mm Hg
ifference in blood pressure lowering translated to a higher
ate (19% to 40%) of fatal coronary artery disease, nonfatal
yocardial infarction, stroke, and heart failure. This group-
pecific analysis led to a change in practice regarding the
rst-line management of hypertension. In the same way,
tudies of Asian-American groups may find more effective,
pecific preventive and treatment regimens. In an era of
ost-effective and personalized medicine, we still do not
ave a risk factor profile or optimal treatment for a large
roup of our patients. Thus, it is crucial that we study this
roup.
ow Do We Study This Group?
ut how do we study a group that is made up of people from
60 countries, with varying languages, cultures, differing
mmigration status, and socioeconomic mix while account-
ng for acculturation?
To be sure, it is a daunting task, filled with unique
hallenges. However, there are some broad foundations that
an be established to help guide the studies. To save cost
nd adequately power the study, investigators should focus
n clustering Asian groups to capture large patient numbers.
he groups could be divided into East Asian, South Asian,
outheast Asian, and Hawaiian and Pacific Islanders, be-
ause these groups have shown a similar risk profile in the
ast (6). There is a need for a systematic approach to
ecruitment as well as compensation for certain language
nd cultural barriers of each group. To get a larger response,
nvestigators could target specific geographic areas where
here are concentrations of certain Asian groups.
Next, investigators must work together to devise stan-
ardized definitions of body composition, metabolic syn-
rome, risk factors, and cardiovascular outcomes so the
tudies will be coherent and applicable. Also, it is important
o have both longitudinal and cross-sectional data. Instead
f using valuable resources to conduct numerous small
tudies, a national effort should be made to fund longitudi-
al, multicenter trials of Asian Americans, capturing differ-
nt socioeconomic groups in various phases of acculturation.
n addition to the collection of demographic and physical
xamination data, assessment of laboratory markers of
isease as well as imaging studies should be done in a cohort
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March 9, 2010:974–5 Asian Americans and Cardiometabolic Riskf patients. Markers other than low-density lipoprotein and
igh-density lipoprotein, such as lipoprotein(a), seem to be
mportant in South Asians. Ideally, future studies would
nclude a cohort with laboratory data that would look not
nly at lipid profile, markers of insulin resistance, and
iabetes but also markers of inflammation like high-
ensitivity C-reactive protein to determine if these confer
he same risk in Asian Americans.
One way we can accomplish this would be to oversample
sian Americans in the National Health and Nutrition
xamination Survey (NHANES). Another method could
e to model the study after the NHANES, designed
pecifically for Asian Americans. There is precedence for
uch a NHANES-based study. For example, the New York
ity Health and Nutrition Examination Survey is a
ommunity-based health survey conducted by the New
ork City Department of Health and Mental Hygiene that
s similar to NHANES. There will be numerous challenges
or these types of studies. For instance, most likely the
tudies will only capture legal immigrants. Also, there will
e difficulty assessing acculturation. However, the benefits
rom such studies are great.
This is an important and unique opportunity to system-
tically study Asian Americans. Prospectively studying the
sian-American population will give us an opportunity to
ee how cardiometabolic risk changes over time and how
est to prevent such risks and how best to treat Asian
mericans.
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